Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Neo Soma Healthcare vs Renlo Health

By GLP-1 ScorecardUpdated

Neo Soma Healthcare
Site position #237

Lower grade

Renlo Health
Site position #41

Higher grade

Score comparison

Renlo Health has the higher recorded score — 79.7/100 to 65.8/100.

Renlo Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. One of the few programs whose headline is the actual monthly rate, with the prescribing physician and the dispensing pharmacy both named.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueRenlo Health +18
66
84
Dose & formulationEven
72
72
Clinical oversightRenlo Health +16
72
88
Labs & monitoringNeo Soma Healthcare +4
62
58
FulfillmentRenlo Health +33
57
90
Contract termsRenlo Health +35
55
90
Neo Soma Healthcare · top barRenlo Health · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricNeo Soma HealthcareRenlo Health
WeighScore65.8/10079.7/100
GradeCC+
Site position#237#41
Semaglutide$199/mo$199/mo, billed monthly at every dose
Tirzepatide$330/mo$269/mo, billed monthly at every dose
CoverageCoverage not publishedNot publicly listed
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Neo Soma Healthcare

Site position #237 · C

Strengths

  • LegitScript verification badge present
  • Publishes the FDA compounded-medication disclaimer
  • Pricing shown publicly for all 6 product lines
  • Multi-product platform (GLP-1, sexual health, peptide therapies)
  • First-month discount on semaglutide ($99 entry)

What to consider

  • Pharmacy partner not named (503A vs 503B unclear)
  • States served not listed — no per-state availability table
  • No named medical director
  • Standard semaglutide pricing ($199/mo) above the cheapest providers ($150–180/mo)
  • Tirzepatide entry pricing ($330) above the cheapest providers (~$200–250/mo)
Renlo Health

Site position #41 · C+

Strengths

  • The headline is the real month-to-month rate — no prepay division and no commitment behind an asterisk
  • A genuine all-in line: medication, injection supplies, provider evaluation, ongoing care, expedited shipping and unlimited care-team messaging, with no membership or consultation fees
  • Names the prescribing physician, Dr. Sean Arora, MD, and the dispensing pharmacy, VialsRX
  • Same price at every dose with a price-lock badge
  • A four-month money-back guarantee, and cancel anytime with no fee

What to consider

  • A struck-through $399 sits beside the price with no published basis — Renlo never says what it was, when it applied or to whom
  • That strikethrough comes from a stylesheet rule rather than a struck-out element, so a markup-level check would report the page clean
  • A comparison table headed "Most GLP-1 providers" quotes $270, $365 and $445 by dose while naming no provider and citing no source
  • A site-wide $50 code means the advertised figure is not the first amount charged
  • No lab protocol is published, and there is no oral or brand route

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard